SEAT says EU’s reversal of combustion-engine ban would help EV transition

The European Union is set to vote on the Mercosur trade deal next week, as confirmed by Denmark. This decision comes amid ongoing discussions about trade agreements that could significantly impact economic relations between the EU and South American countries involved in Mercosur.

The European Union has agreed to indefinitely freeze Russian assets, a decision aimed at facilitating a loan to Ukraine amidst its ongoing financial crisis. This move addresses the urgent need for financial support as Ukraine faces a projected cash shortfall of approximately €135.7 billion over the next two years due to the ongoing conflict with Russia.

The European Union has endorsed an indefinite freeze on Russian assets, a decision made in light of Ukraine's urgent financial needs as it faces a cash shortfall of approximately €135.7 billion over the next two years due to ongoing conflict. This move aims to bolster Ukraine's economy amidst the prolonged war with Russia.

The European Commission is expected to announce a significant reduction in the scope of its 2035 ban on new petrol and diesel cars, according to a senior Member of the European Parliament. This decision has sparked concerns among environmental campaigners, who argue that it undermines the EU's green deal and its commitment to combating climate change.

Google is reportedly facing a significant fine from the European Union next year for allegedly favoring its own services over competitors, a move that underscores ongoing scrutiny of the tech giant's market practices. This potential penalty reflects the EU's commitment to enforcing competition laws in the digital sector.

EU regulators conducted an unannounced raid on Temu's Dublin headquarters as part of an investigation into potential violations of foreign subsidy regulations. This action comes amid ongoing scrutiny of the Chinese online retailer, which is already facing allegations regarding the sale of illegal content on its platform.

The European Union has decided to shorten the exclusivity period for new drugs, allowing cheaper generics to enter the market a year earlier than previously allowed. This move aims to reduce healthcare costs and increase access to medications for patients across the EU.